共查询到20条相似文献,搜索用时 31 毫秒
1.
Adipo(cyto)kines are mostly produced by adipose tissue and orchestrate the adverse
impact of excess adiposity on cardiovascular risk. Adipokines also contribute
importantly to the pathophysiology of rheumatoid arthritis. Congruent with data
reported in previous investigations, Kang and colleagues report in this issue of
Arthritis Research & Therapy that adipokine concentrations are
further associated with metabolic risk and inflammation and that the
leptin–adiponectin ratio associates with the carotid artery resistive index in
rheumatoid arthritis. Guided by evidence reported thus far on cardiovascular risk, we
discuss six reasons why careful elucidation of adipokine–cardiovascular risk
relations is needed in rheumatoid arthritis.In this issue of Arthritis Research & Therapy, Kang and colleagues
investigate whether adipokines could link inflammation, metabolic risk factors and
cardiovascular disease in rheumatoid arthritis (RA) [1]. Evidence in support of this paradigm was reported previously [2-6]. Patients with RA experience a markedly increased cardiovascular risk that is
driven by metabolic risk factors and by high-grade inflammation [7]. Kang and colleagues measured adiponectin, leptin, resistin, tumor necrosis
factor alpha and interleukin-6 concentrations and assessed the common carotid artery
intima-media thickness, resistive index (RI) and plaque presence by high-resolution
ultrasonography [1]. Concentrations of some of the adipokines related to inflammatory markers
including C-reactive protein levels and the erythrocyte sedimentation rate, and to
metabolic syndrome features.In a previous study by our group, leptin and adiponectin concentrations were not
associated with carotid intima-media thickness and plaque [3]. In addition, the leptin–adiponectin ratio and carotid RI as markers of
cardiovascular risk have not been reported in RA. For these reasons, besides the
abovementioned analyses, Kang and colleagues assessed (only) the relationship of the
leptin–adiponectin ratio with carotid RI. In univariate analysis, the
leptin–adiponectin ratio as well as age, homeostasis model assessment for insulin
resistance, waist circumference and body mass index were associated with the carotid RI.
Importantly, in multivariate analysis, only age and the leptin–adiponectin ratio
remained significantly related to the carotid RI. The leptin–adiponectin ratio may
thus provide information about the presence of subclinical cardiovascular disease beyond
that on insulin resistance as assessed by the homeostasis model of insulin resistance,
as well as adiposity extent as represented by body mass index and waist circumference in
RA.Adipo(cyto)kines comprise a vast range of disparate soluble bioactive proteins that are
mostly secreted by adipose tissue [8]. These molecules participate in biological processes that include
inflammatory responses and thereby orchestrate the adverse impact of excess adiposity on
cardiovascular risk and incident type 2 diabetes [8]. Adipokines represent both adiposity extent and biological activity. RA is a
prototypic inflammatory disease. In this context, ~200 recently reported investigations
substantiate an important involvement of adipokines in RA activity and severity [9]. By contrast, despite the contribution of adipokines to altered
cardiovascular risk in non-RA subjects and the enhanced cardiovascular risk in RA, there
is a striking paucity of reported studies on the potential role of adipokines in
atherogenesis in RA.A myriad of pertinent reasons exist why the role of adipokines in cardiovascular risk
amongst patients with RA requires thorough elucidation. First, RA can modify adipokine
production [3,9].Second, and presumably more important, the presence of autoimmunity can alter the
effects of adipokines on cardiovascular risk [3,4]. In non-RA subjects, adiponectin production decreases with increasing
adiposity and this adipokine has anti-inflammatory properties [8]. However, in RA adiponectin has marked proinflammatory properties [9]. In fact, in Kang and colleagues’ study the adiponectin concentrations
were paradoxically positively associated with the erythrocyte sedimentation rate [1]. Whereas in non-RA subjects adiponectin improves metabolic risk and also
directly inhibits atherogenesis, we reported recently that in RA, upon using
comprehensive potential confounder-adjusted analysis, adiponectin concentrations
associated paradoxically with high blood pressure [3,4] and in white but not black Africans with enhanced endothelial activation [4]. Endothelial activation mediates the very initial stages of atherosclerosis [3-6]. Whether such paradoxical relations represent altered effects mediated by RA
or a compensatory increase in adiponectin production in the presence of heightened
cardiovascular risk and in an attempt to reduce this risk needs further investigation [4].Third, conventional risk factors and disease characteristics can impact on
adipokine–atherogenesis relationships in RA [5]. Resistin concentrations thus associate independently with endothelial
activation in RA, but this relation is present only in those with, and not in those
without, traditional risk factors, abdominal obesity, joint damage as reflected by the
presence of deformed joints or prolonged disease duration [5]. This observation further supports the need for sensitivity analysis in the
present context. By contrast, interleukin-6 concentrations are more consistently
associated with endothelial activation in RA [6].Fourth, the effects of adipokines on cardiovascular risk require examination prior to
targeting the respective molecules in an attempt to reduce disease activity and severity
in RA [3]. Indeed, should the protective effect of adiponectin on cardiovascular risk
be preserved amongst patients with RA, then its blockade would be expected to further
enhance cardiovascular risk [3].Fifth, RA influences adiposity and its distribution, which also associates with
atherosclerosis in this disease [7,10].Finally, as illustrated by the disparity in adiponectin–endothelial activation
relations amongst Africans previously alluded to, population origin impacts on
adipokine–cardiovascular risk relations in RA [4].A caveat of Kang and colleagues’ study is that potential confounders were not
systematically identified. For example, gender, cardiovascular drug use, antirheumatic
agent use and the glomerular filtration rate can all influence both the concentrations
and effects of adipokines [3-6]. Nevertheless, this investigation reinforces previously reported evidence
that strongly suggests an intriguing and important involvement of adipokines in RA
atherogenesis. 相似文献
2.
Lalit Ponnala Anne-Marie Stomp Donald L Bitzer Mladen A Vouk 《EURASIP Journal on Bioinformatics and Systems Biology》2006,2006(1):23613-9
A decoding algorithm is tested that mechanistically models the progressive alignments that arise as the mRNA moves past the rRNA tail during translation elongation. Each of these alignments provides an opportunity for hybridization between the single-stranded, -terminal nucleotides of the 16S rRNA and the spatially accessible window of mRNA sequence, from which a free energy value can be calculated. Using this algorithm we show that a periodic, energetic pattern of frequency 1/3 is revealed. This periodic signal exists in the majority of coding regions of eubacterial genes, but not in the non-coding regions encoding the 16S and 23S rRNAs. Signal analysis reveals that the population of coding regions of each bacterial species has a mean phase that is correlated in a statistically significant way with species () content. These results suggest that the periodic signal could function as a synchronization signal for the maintenance of reading frame and that codon usage provides a mechanism for manipulation of signal phase.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32] 相似文献
3.
Shu-Qin Zhang Morihiro Hayashida Tatsuya Akutsu Wai-Ki Ching Michael K Ng 《EURASIP Journal on Bioinformatics and Systems Biology》2007,2007(1):20180
A Boolean network is a model used to study the interactions between different genes in genetic regulatory networks. In this paper, we present several algorithms using gene ordering and feedback vertex sets to identify singleton attractors and small attractors in Boolean networks. We analyze the average case time complexities of some of the proposed algorithms. For instance, it is shown that the outdegree-based ordering algorithm for finding singleton attractors works in time for , which is much faster than the naive time algorithm, where is the number of genes and is the maximum indegree. We performed extensive computational experiments on these algorithms, which resulted in good agreement with theoretical results. In contrast, we give a simple and complete proof for showing that finding an attractor with the shortest period is NP-hard.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32] 相似文献
4.
Rheumatoid arthritis (RA) is a progressive autoimmune disease characterized by
synovial membrane hyperplasia, inflammation, and angiogenesis. Hepatocyte growth
factor (HGF) and its receptor, c-Met, are both overexpressed in the RA synovium.
NK4 is an antagonist of HGF which has been shown to inhibit tumor growth,
metastasis, and angiogenesis. In an experimental model of RA, NK4 gene therapy
inhibited joint damage and inflammation in both preventative and therapeutic
models. NK4 treatment therefore represents a possible therapeutic option in
combating RA.Rheumatoid arthritis (RA) is a progressive, inflammatory autoimmune disease
characterized by an erosive synovitis. In addition to being an inflammatory
condition, RA is also considered to be a member of the angiogenic family of
diseases. Angiogenesis is growth of new blood vessels from pre-existing blood
vessels. As the disease progresses, the hyperplastic synovial pannus creates a
hypoxic, inflammatory environment that induces angiogenesis. Further vascularization
of the synovial tissue promotes pannus growth and continued infiltration of
inflammatory leukocytes, thus perpetuating the disease.In the previous issue of Arthritis Research & Therapy, Tsunemi and
colleagues [1] reported on the targeting of hepatocyte growth factor (HGF) by NK4 in the
treatment of RA. HGF is a pleiotropic growth factor that is expressed by mesenchymal
cells and promotes processes such as mitogenesis, differentiation, and angiogenesis [2]. It mediates these functions via binding to its unique receptor c-Met, a
receptor tyrosine kinase. c-Met is expressed by a variety of cell types, including
endothelial cells (ECs) [3].We have previously shown that HGF is elevated in the synovial fluid of patients with
RA [4]. More recently, Grandaunet and colleagues [5] found that plasma levels of HGF predict the severity of joint damage in
patients with RA. In the joint, we found that HGF and c-Met are elevated in the RA
synovial lining compared with normal controls [4]. The report by Tsunemi and colleagues [1] supports these findings and further shows that c-Met is expressed on
fibroblasts, mononuclear cells, and ECs in the RA synovium.HGF is a heterodimeric protein composed of an ?-chain, which contains four kringle
domains, and a ?-chain [6]. The ?-chain binds c-Met with high affinity, whereas the ?-chain is
responsible for activation of c-Met. In an attempt to inhibit HGF, Date and
colleagues [7] generated a cleavage product of HGF termed NK4, which contains the four
kringle domains of the HGF ?-chain. Therefore, NK4 serves as an antagonist of HGF
and can bind c-Met with high affinity without activating it.As described above, one of the primary functions of HGF is to induce angiogenesis by
binding to c-Met on the surface of ECs. Therefore, it was postulated that NK4 would
act as a competitive inhibitor of HGF, thus inhibiting angiogenesis. Indeed, NK4 has
been shown to inhibit angiogenesis in vitro and in various in vivo
cancer models [6,8,9]. However, in addition to having antagonistic action against HGF, NK4
inhibits angiogenesis induced by vascular endothelial growth factor and basic
fibroblast growth factor in a c-Met-independent fashion [9]. In addition to c-Met, NK4 binds to perlecan, a sulfate proteoglycan that
interacts with the vascular endothelial basement membrane. Sakai and colleagues [9] found, specifically, that NK4 binds perlecan and prevents proper
fibronectin assembly in the basement membrane, which inhibits several facets of
angiogenesis.These features of NK4 make it an attractive potential adjunctive therapy in
angiogenic diseases. Over the past decade, numerous studies have been performed to
assess the efficacy of either a recombinant NK4 protein or NK4 gene expression
vector in many experimental cancer models [3,6]. Collectively, these studies have indicated that NK4 treatment has the
potential to inhibit tumor growth, angiogenesis, and metastasis [3,6]. Much of the preclinical success of NK4 can be attributed to its ability
to inhibit multiple pathways involved in growth and angiogenesis.RA is driven by inflammation and angiogenesis, and thus much work has been aimed at
identifying and testing potential angiogenesis inhibitors in models of experimental
arthritis [10]. Tsunemi and colleagues [1] have now adopted their approach of studying the antiangiogenic properties
of NK4 in cancer to experimental arthritis. Using an adenovirus vector containing
the NK4 gene, they found that NK4 inhibited the development of ?-glucan-induced
arthritis [1]. NK4 was able to inhibit inflammation, joint swelling, and bone erosion.
However, the authors did not show direct evidence of NK4 inhibiting synovial blood
vessel density. Importantly, they also showed that NK4 gene therapy was effective
when given therapeutically, after the onset of the experimental arthritis [1].These results are highly encouraging in the application of NK4 as a potential
adjunctive RA therapy. This report, coupled with the high expression levels of HGF
and c-Met in the RA synovium, makes NK4 treatment an intriguing possibility. In the
future, it will be of great interest to determine whether these effects of NK4 are
observable in other animal models of RA, as not all facets of RA are represented in
a singular model of the disease. Moreover, many of the effects of NK4 observed by
Tsunemi and colleagues [1] are attributed to a reduction in inflammation and inflammatory cytokines.
Therefore, elucidating the anti-inflammatory and antiangiogenic mechanisms of NK4
will be paramount to transitioning from an interesting candidate to a possible RA
therapy. 相似文献
5.
6.
Michael A. Weiss 《The Journal of biological chemistry》2009,284(29):19159-19163
Insulin plays a central role in the regulation of vertebrate metabolism. The hormone, the post-translational product of a single-chain precursor, is a globular protein containing two chains, A (21 residues) and B (30 residues). Recent advances in human genetics have identified dominant mutations in the insulin gene causing permanent neonatal-onset DM2 (1–4). The mutations are predicted to block folding of the precursor in the ER of pancreatic β-cells. Although expression of the wild-type allele would in other circumstances be sufficient to maintain homeostasis, studies of a corresponding mouse model (5–7) suggest that the misfolded variant perturbs wild-type biosynthesis (8, 9). Impaired β-cell secretion is associated with ER stress, distorted organelle architecture, and cell death (10). These findings have renewed interest in insulin biosynthesis (11–13) and the structural basis of disulfide pairing (14–19). Protein evolution is constrained not only by structure and function but also by susceptibility to toxic misfolding.Insulin plays a central role in the regulation of vertebrate metabolism. The hormone, the post-translational product of a single-chain precursor, is a globular protein containing two chains, A (21 residues) and B (30 residues). Recent advances in human genetics have identified dominant mutations in the insulin gene causing permanent neonatal-onset DM2 (1–4). The mutations are predicted to block folding of the precursor in the ER of pancreatic β-cells. Although expression of the wild-type allele would in other circumstances be sufficient to maintain homeostasis, studies of a corresponding mouse model (5–7) suggest that the misfolded variant perturbs wild-type biosynthesis (8, 9). Impaired β-cell secretion is associated with ER stress, distorted organelle architecture, and cell death (10). These findings have renewed interest in insulin biosynthesis (11–13) and the structural basis of disulfide pairing (14–19). Protein evolution is constrained not only by structure and function but also by susceptibility to toxic misfolding. 相似文献
7.
Decomposing a biological sequence into its functional regions is an important prerequisite to understand the molecule. Using the multiple alignments of the sequences, we evaluate a segmentation based on the type of statistical variation pattern from each of the aligned sites. To describe such a more general pattern, we introduce multipattern consensus regions as segmented regions based on conserved as well as interdependent patterns. Thus the proposed consensus region considers patterns that are statistically significant and extends a local neighborhood. To show its relevance in protein sequence analysis, a cancer suppressor gene called p53 is examined. The results show significant associations between the detected regions and tendency of mutations, location on the 3D structure, and cancer hereditable factors that can be inferred from human twin studies.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27] 相似文献
8.
9.
JZ Song KM Duan T Ware M Surette 《EURASIP Journal on Bioinformatics and Systems Biology》2007,2007(1):39382
A variety of high-throughput methods have made it possible to generate detailed temporal expression data for a single gene or large numbers of genes. Common methods for analysis of these large data sets can be problematic. One challenge is the comparison of temporal expression data obtained from different growth conditions where the patterns of expression may be shifted in time. We propose the use of wavelet analysis to transform the data obtained under different growth conditions to permit comparison of expression patterns from experiments that have time shifts or delays. We demonstrate this approach using detailed temporal data for a single bacterial gene obtained under 72 different growth conditions. This general strategy can be applied in the analysis of data sets of thousands of genes under different conditions.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29] 相似文献
10.
11.
12.
Francesco Fabris Andrea Sgarro Alessandro Tossi 《EURASIP Journal on Bioinformatics and Systems Biology》2007,2007(1):31450
Mathematical tools developed in the context of Shannon information theory were used to analyze the meaning of the BLOSUM score, which was split into three components termed as the BLOSUM spectrum (or BLOSpectrum). These relate respectively to the sequence convergence (the stochastic similarity of the two protein sequences), to the background frequency divergence (typicality of the amino acid probability distribution in each sequence), and to the target frequency divergence (compliance of the amino acid variations between the two sequences to the protein model implicit in the BLOCKS database). This treatment sharpens the protein sequence comparison, providing a rationale for the biological significance of the obtained score, and helps to identify weakly related sequences. Moreover, the BLOSpectrum can guide the choice of the most appropriate scoring matrix, tailoring it to the evolutionary divergence associated with the two sequences, or indicate if a compositionally adjusted matrix could perform better.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29] 相似文献
13.
14.
Parikshit Sondhi Purushottam Raj V Vinod Kumar Ankush Mittal 《EURASIP Journal on Bioinformatics and Systems Biology》2007,2007(1):28576
The exponential growth in the volume of publications in the biomedical domain has made it impossible for an individual to keep pace with the advances. Even though evidence-based medicine has gained wide acceptance, the physicians are unable to access the relevant information in the required time, leaving most of the questions unanswered. This accentuates the need for fast and accurate biomedical question answering systems. In this paper we introduce INDOC—a biomedical question answering system based on novel ideas of indexing and extracting the answer to the questions posed. INDOC displays the results in clusters to help the user arrive the most relevant set of documents quickly. Evaluation was done against the standard OHSUMED test collection. Our system achieves high accuracy and minimizes user effort.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24] 相似文献
15.
16.
17.
18.
Early onset generalized dystonia (DYT1) is an autosomal dominant neurological disorder caused by deletion of a single glutamate residue (torsinA ΔE) in the C-terminal region of the AAA+ (ATPases associated with a variety of cellular activities) protein torsinA. The pathogenic mechanism by which torsinA ΔE mutation leads to dystonia remains unknown. Here we report the identification and characterization of a 628-amino acid novel protein, printor, that interacts with torsinA. Printor co-distributes with torsinA in multiple brain regions and co-localizes with torsinA in the endoplasmic reticulum. Interestingly, printor selectively binds to the ATP-free form but not to the ATP-bound form of torsinA, supporting a role for printor as a cofactor rather than a substrate of torsinA. The interaction of printor with torsinA is completely abolished by the dystonia-associated torsinA ΔE mutation. Our findings suggest that printor is a new component of the DYT1 pathogenic pathway and provide a potential molecular target for therapeutic intervention in dystonia.Early onset generalized torsion dystonia (DYT1) is the most common and severe form of hereditary dystonia, a movement disorder characterized by involuntary movements and sustained muscle spasms (1). This autosomal dominant disease has childhood onset and its dystonic symptoms are thought to result from neuronal dysfunction rather than neurodegeneration (2, 3). Most DYT1 cases are caused by deletion of a single glutamate residue at positions 302 or 303 (torsinA ΔE) of the 332-amino acid protein torsinA (4). In addition, a different torsinA mutation that deletes amino acids Phe323–Tyr328 (torsinA Δ323–328) was identified in a single family with dystonia (5), although the pathogenic significance of this torsinA mutation is unclear because these patients contain a concomitant mutation in another dystonia-related protein, ϵ-sarcoglycan (6). Recently, genetic association studies have implicated polymorphisms in the torsinA gene as a genetic risk factor in the development of adult-onset idiopathic dystonia (7, 8).TorsinA contains an N-terminal endoplasmic reticulum (ER)3 signal sequence and a 20-amino acid hydrophobic region followed by a conserved AAA+ (ATPases associated with a variety of cellular activities) domain (9, 10). Because members of the AAA+ family are known to facilitate conformational changes in target proteins (11, 12), it has been proposed that torsinA may function as a molecular chaperone (13, 14). TorsinA is widely expressed in brain and multiple other tissues (15) and is primarily associated with the ER and nuclear envelope (NE) compartments in cells (16–20). TorsinA is believed to mainly reside in the lumen of the ER and NE (17–19) and has been shown to bind lamina-associated polypeptide 1 (LAP1) (21), lumenal domain-like LAP1 (LULL1) (21), and nesprins (22). In addition, recent evidence indicates that a significant pool of torsinA exhibits a topology in which the AAA+ domain faces the cytoplasm (20). In support of this topology, torsinA is found in the cytoplasm, neuronal processes, and synaptic terminals (2, 3, 15, 23–26) and has been shown to bind cytosolic proteins snapin (27) and kinesin light chain 1 (20). TorsinA has been proposed to play a role in several cellular processes, including dopaminergic neurotransmission (28–31), NE organization and dynamics (17, 22, 32), and protein trafficking (27, 33). However, the precise biological function of torsinA and its regulation remain unknown.To gain insights into torsinA function, we performed yeast two-hybrid screens to search for torsinA-interacting proteins in the brain. We report here the isolation and characterization of a novel protein named printor (protein interactor of torsinA) that interacts selectively with wild-type (WT) torsinA but not the dystonia-associated torsinA ΔE mutant. Our data suggest that printor may serve as a cofactor of torsinA and provide a new molecular target for understanding and treating dystonia. 相似文献
19.
Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO 总被引:24,自引:8,他引:16
下载免费PDF全文
![点击此处可从《Molecular and cellular biology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Vania Gelmetti Jinsong Zhang Mirco Fanelli Saverio Minucci Pier Giuseppe Pelicci Mitchell A. Lazar 《Molecular and cellular biology》1998,18(12):7185-7191
20.
Thomas Farkas Yulia A. Kutskova Vincenzo Zimarino 《Molecular and cellular biology》1998,18(2):906-918